The significance of EGFR mutations associated with prognosis of early-stage NSCLC has been reported, along with various factors such as age, histologic pattern, pathologic stage, and presence of lymphovascular invasion [29,30,31,32,33]. Here, EGFR is linked to non-small cell lung carcinoma.